Gwrthrychau elusennol
TO ADVANCE THE SCIENCE AND PRACTICE OF GENE THERAPY FOR THE PUBLIC BENEFIT, IN PARTICULAR (BUT NOT EXCLUSIVELY) BY:
I ADVANCING DIFFUSION OF SCIENTIFIC KNOWLEDGE IN THE FIELD OF GENE AND CELL THERAPY;
II FACILITATING SHARING OF SCIENTIFIC RESOURCES IN THE FIELD OF GENE AND CELL THERAPY;
III FACILITATING CLINICAL ADVANCEMENT OF GENE AND CELL THERAPY TECHNOLOGY; AND
IV PROVIDING EXPERT ADVICE TO STRATEGIC, REGULATORY, ETHICAL AND FUNDING BODIES IN THE UK.
